Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Yan Xia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5323-0614; OpenAlex author ID A5101894167. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. Exploring the efficacy and safety of drug-eluting beads transarterial chemoembolization in pancreatic cancer liver metastasis. Co-author DOI 10.1093/bjr/tqae059↗
  2. Combined ablation-chemotherapy versus chemotherapy alone for pancreatic cancer with liver metastasis: a propensity score matching study. Co-author DOI 10.1080/17474124.2021.1869937↗
  3. High-intensity focused ultrasound enhances the effect of bufalin by inducing apoptosis in pancreatic cancer cells. Co-author DOI 10.2147/ott.s185953↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhouyu Ning · 3 shared papers, 2019–2024 · strength 0.48
  2. Yongqiang Hua · 2 shared papers, 2021–2024 · strength 0.39
  3. Zhiqiang Meng · 1 shared paper, 2024 · strength 0.26
  4. Liping Zhuang · 2 shared papers, 2019–2021 · strength 0.22
  5. Zhiqiang Meng · 2 shared papers, 2019–2021 · strength 0.22
  6. Yehua Shen · 1 shared paper, 2021 · strength 0.13
  7. Chenyue Zhang · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.